Rankings
▼
Calendar
CAMP FY 2024 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
CAMP
CAMP4 Therapeutics Corporation
$125M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$652,000
+86.3% YoY
Gross Profit
$652,000
100.0% margin
Operating Income
-$53M
-8142.3% margin
Net Income
-$52M
-7943.4% margin
EPS (Diluted)
$-2.66
Cash Flow
Operating Cash Flow
-$46M
Free Cash Flow
-$46M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$78M
Total Liabilities
$15M
Stockholders' Equity
$63M
Cash & Equivalents
$64M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$652,000
$350,000
+86.3%
Gross Profit
$652,000
$350,000
+86.3%
Operating Income
-$53M
-$52M
-2.3%
Net Income
-$52M
-$49M
-5.1%
← Q4 2023
All Quarters
Q1 2024 →